Cap Diagnostics LLC

Cap Diagnostics LLC was paid $10.76M by Medicaid between Jan 2018 and Nov 2024, across 37 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 64% of everything it billed.

33Billing provider infoCAP DIAGNOSTICS LLC
IRVINE, CA 92618

33aNPI1659655124assigned 10/03/2011

33bProvider typeClinical Medical Laboratory

28Total paid$10.76M

24GClaims280,934

24DCodes billed37

24AFirst – last monthJan 2018 – Nov 2024

Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#71 of 561

Median peer was paid$222K

This provider vs. median49×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	10,662	$158K
2019	14,821	$195K
2020	58,921	$2.77M
2021	104,712	$4.27M
2022	77,985	$2.93M
2023	11,378	$383K
2024incomplete	2,455	$57K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	64%	107,009	48,968	$6.93M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	7.2%	42,058	18,466	$778K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	6.2%	9,303	8,037	$670K
88305	Level IV - Surgical pathology, gross and microscopic examination	4.1%	15,205	14,385	$445K
88377		3.0%	1,079	1,066	$318K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	2.4%	7,552	5,414	$259K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	2.3%	8,264	7,124	$251K
87481		1.7%	8,464	7,364	$178K
88342		1.3%	9,687	9,482	$140K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	1.3%	1,910	855	$139K
88120		1.0%	1,077	974	$112K
87640		<1%	9,070	8,029	$67K

25 more codes

87653		<1%	9,114	$66K
87500		<1%	8,691	$66K
87529		<1%	5,894	$57K
88313		<1%	7,654	$55K
87496		<1%	5,926	$44K
87532		<1%	5,853	$41K
88360		<1%	1,450	$29K
88112		<1%	3,520	$24K
87511		<1%	2,966	$19K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	2,417	$19K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	1,249	$11K
88341		<1%	751	$10K
87482		<1%	740	$10K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	1,257	$10K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	1,066	$7K
88142		<1%	268	$2K
87631		<1%	84	$2K
87186		<1%	206	$1K
88141		<1%	122	$1K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	<1%	83	$1K
87556		<1%	115	$1K
88312		<1%	155	$1K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	199	$1K
81003		<1%	462	$281.32
87641		<1%	14	$35.09

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDELBRIDGE, PAMELA (COMPLIANCE)

Same official

Other billing entities under DELBRIDGE, PAMELA

Full network →

Provider	Location	Paid
Cap Diagnostics LLC	Lake Mary, FL	$643K
Cap Diagnostics LLC	Royal Oak, MI	$125K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.